Cargando…

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension

BACKGROUND & AIMS: Official guidelines do not recommend hepatic resection (HR) for patients with hepatocellular carcinoma (HCC) and portal hypertension (PHT). This study aims to investigate the safety and efficacy of HR for patients with HCC and PHT. METHODS: Mortality and survival after HR were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Jian-Hong, Li, Hang, Xiao, Nan, Ye, Xin-Ping, Ke, Yang, Wang, Yan-Yan, Ma, Liang, Chen, Jie, You, Xue-Mei, Zhang, Zhi-Yuan, Lu, Shi-Dong, Li, Le-Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182657/ https://www.ncbi.nlm.nih.gov/pubmed/25268959 http://dx.doi.org/10.1371/journal.pone.0108755

Ejemplares similares

Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus
por: Su, Fang, et al.
Publicado: (2018)

Comparison of liver resection and transplantation for Child-pugh A cirrhotic patient with very early hepatocellular carcinoma and portal hypertension
por: Dai, Yan, et al.
Publicado: (2014)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma
por: Chen, Kang, et al.
Publicado: (2022)

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
por: He, Wei, et al.
Publicado: (2015)

Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
por: Azoulay, Daniel, et al.
Publicado: (2020)

Hepatic Resection for Hepatocellular Carcinoma in Patients With Portal Hypertension: A Long-Term Benefit Compared With Transarterial Chemoembolization and Thermal Ablation
por: Xiao, Hua, et al.
Publicado: (2015)

Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report
por: Harimoto, Norifumi, et al.
Publicado: (2020)

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
por: Zhang, Xiu-Ping, et al.
Publicado: (2017)

Controversies and evidence of hepatic resection for hepatocellular carcinoma()
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
por: XIAO, CHENG-ZUO, et al.
Publicado: (2015)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Zheng, Ninggang, et al.
Publicado: (2016)

Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma within Milan criteria: A propensity score matching analysis
por: Guo, Zhe, et al.
Publicado: (2017)

Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure
por: Xiang, Xiao, et al.
Publicado: (2017)

Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?
por: Barros, Andrea Zaidan de Almeida, et al.
Publicado: (2022)

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection
por: Zhong, Jian-Hong, et al.
Publicado: (2016)

Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update
por: Ye, Jia-Zhou, et al.
Publicado: (2017)

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy
por: Ke, Yang, et al.
Publicado: (2013)

High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma
por: Wang, Yan-Yan, et al.
Publicado: (2017)

The impact of hepatic steatosis on portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Portal Hypertension in Alcohol-Associated Hepatitis
por: McConnell, Matthew J., et al.
Publicado: (2023)

The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection
por: Li, Chuan, et al.
Publicado: (2019)

In situ subtotal spleen resection combined with selective pericardial devascularization for the treatment of portal hypertension
por: Li, Hai-Lin, et al.
Publicado: (2023)

In-hospital Mortality after Surgical Resection in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus
por: Zhang, Xiu-Ping, et al.
Publicado: (2019)

Pancreaticoduodenectomy for hepatic portal lymph node metastasis after hepatic resection for hepatocellular carcinoma: A clinical case report
por: Son, Tran Que, et al.
Publicado: (2021)

Portal vein resection and reconstruction with artificial blood vessels is safe and feasible for pancreatic ductal adenocarcinoma patients with portal vein involvement: Chinese center experience
por: Xie, Zhi-Bo, et al.
Publicado: (2017)

Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension
por: Chen, Xiao, et al.
Publicado: (2023)

Laparoscopic Left Hepatectomy with Middle Hepatic Vein Resection for Hepatocellular Carcinoma with Extrahepatic Portal Vein Obstruction
por: Umemura, Akira, et al.
Publicado: (2021)

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients
por: Chen, Chang-Zhi, et al.
Publicado: (2021)

Significance of Simultaneous Splenic Artery Resection in Left-Sided Portal Hypertension After Pancreaticoduodenectomy with Combined Portal Vein Resection
por: Gyoten, Kazuyuki, et al.
Publicado: (2017)

Salvianolic Acid B Reducing Portal Hypertension Depends on Macrophages in Isolated Portal Perfused Rat Livers with Chronic Hepatitis
por: Zhao, Xin, et al.
Publicado: (2012)

A safe and simple exposure and Pringle maneuver in laparoscopic anatomical liver resection of segment 7
por: Li, YongKun, et al.
Publicado: (2023)

Therapeutic Evaluation of Radiotherapy with Contrast-Enhanced Ultrasound in Non-Resectable Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
por: Li, Hongxue, et al.
Publicado: (2018)

Hepatic Resection is Safe for Metachronous Hepatic Metastases from Ovarian Cancer
por: Niu, Guang-cai, et al.
Publicado: (2012)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yin, Jun, et al.
Publicado: (2017)

Hepatic lipocalin 2 promotes liver fibrosis and portal hypertension
por: Chen, Jiegen, et al.
Publicado: (2020)

Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension
por: Zhang, Er-lei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8aasfjsvi003es0usph1eikae4